54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 05
13:27 UTC
|
FBIN
Fortune Brands Innovations
|
◎ Target | Matthew Bouley ★★★☆☆ #1427 | Equal Weight | $56.00→ $54.00-3.6% |
|
Aug 05
13:27 UTC
|
EMR
Emerson Electric
|
◎ Target | Deane Dray ★★★☆☆ #1828 | Outperform | $169.00→ $179.00+5.9% |
|
Aug 05
13:27 UTC
|
CTRI
Centuri
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $46.00→ $35.00-23.9% |
|
Aug 05
13:27 UTC
|
BKNG
Booking
|
◎ Target | Deepak Mathivanan ★★★☆☆ #1703 | Neutral | $175.00→ $220.00+25.7% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | Gregory Renza ★★★☆☆ #1227 | Hold | $340.00→ $362.00+6.5% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | firm only | Outperform | $400.00→ $450.00+12.5% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | Terence Flynn ★★★☆☆ #1095 | Equal Weight | $333.00→ $351.00+5.4% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | firm only | Outperform | $370.00→ $400.00+8.1% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | firm only | Underperform | $215.00→ $230.00+7.0% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | firm only | Underperform | $312.00→ $317.00+1.6% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | Gary Nachman ★★★☆☆ #1302 | Hold | $366.00→ $384.00+4.9% |
|
Aug 05
13:27 UTC
|
AMGN
Amgen
|
◎ Target | firm only | Equal Weight | $390.00→ $400.00+2.6% |
|
Aug 05
13:27 UTC
|
VGNT
Versigent
|
↓ Downgrade | firm only | Overweight→ Equal Weight | |
|
Aug 05
13:27 UTC
|
ROL
Rollins
|
↓ Downgrade | firm only | Buy→ Hold | |
|
Aug 05
13:27 UTC
|
PRCT
PROCEPT BioRobotics
|
↓ Downgrade | firm only | Overweight→ Equal Weight | $19.00 |
|
Aug 05
13:27 UTC
|
NJR
NewJersey Resources
|
↓ Downgrade | Constantine Lednev not yet tracked | Overweight→ Equal Weight | $61.00 |
|
Aug 05
13:27 UTC
|
APTV
Aptiv
|
↓ Downgrade | firm only | Overweight→ Equal Weight | |
|
Aug 05
13:27 UTC
|
WAT
Waters
|
↑ Upgrade | Dan Brennan not yet tracked | Hold→ Buy | $475.00 |
|
Aug 05
13:27 UTC
|
DLR
Digital Realty Trust
|
↑ Upgrade | firm only | Hold→ Buy | $212.00 |
|
Aug 05
13:27 UTC
|
BTDR
Bitdeer Technologies Group
|
↑ Upgrade | Brett Knoblauch ★☆☆☆☆ #3220 | Neutral→ Overweight | $15.00→ $18.00+20.0% |
|
Aug 05
13:27 UTC
|
BMY
Bristol Myers Squibb
|
↑ Upgrade | firm only | Hold→ Buy | $75.00 |
|
Aug 05
12:27 UTC
|
ZETA
Zeta Global
|
◎ Target | Scott Berg ★★★★★ #86 | Buy | $25.00→ $30.00+20.0% |
|
Aug 05
12:27 UTC
|
ZBRA
Zebra Technologies
|
◎ Target | James Ricchiuti ★★☆☆☆ #2610 | Buy | $345.00→ $410.00+18.8% |
|
Aug 05
12:27 UTC
|
XGN
Exagen
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $8.00→ $9.00+12.5% |
|
Aug 05
12:27 UTC
|
WK
Workiva
|
◎ Target | Allan Verkhovski ★★★☆☆ #1363 | Buy | $80.00→ $70.00-12.5% |
|
Aug 05
12:27 UTC
|
W
Wayfair
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $83.00→ $133.00+60.2% |
|
Aug 05
12:27 UTC
|
UPST
Upstart
|
◎ Target | Kyle Peterson ★★★☆☆ #1696 | Buy | $40.00→ $42.00+5.0% |
|
Aug 05
12:27 UTC
|
UPST
Upstart
|
◎ Target | Patrick Moley ★★★☆☆ #1855 | Overweight | $46.00→ $51.00+10.9% |
|
Aug 05
12:27 UTC
|
TYGO
Tigo Energy
|
◎ Target | Amit Dayal ★☆☆☆☆ #3182 | Buy | $6.00→ $3.50-41.7% |
|
Aug 05
12:27 UTC
|
TOST
Toast
|
◎ Target | Billy Fitzsimmons ★★★★★ #204 | Overweight | $32.00→ $39.00+21.9% |
|
Aug 05
12:27 UTC
|
TOST
Toast
|
◎ Target | Mayank Tandon ★★★★☆ #398 | Buy | $35.00→ $45.00+28.6% |
|
Aug 05
12:27 UTC
|
SPOT
Spotify Technology
|
◎ Target | Barton Crockett ★★★★☆ #650 | Neutral | $531.00→ $527.00-0.8% |
|
Aug 05
12:27 UTC
|
SPCX
SpaceX
|
◎ Target | Alexander Potter ★☆☆☆☆ #3125 | Neutral | $156.00→ $140.00-10.3% |
|
Aug 05
12:27 UTC
|
SOPH
SOPHiA GENETICS
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2778 | Buy | $12.00→ $14.00+16.7% |
|
Aug 05
12:27 UTC
|
SOPH
SOPHiA GENETICS
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $8.00→ $9.00+12.5% |
|
Aug 05
12:27 UTC
|
SNDX
Syndax Pharmaceuticals
|
◎ Target | Andres Y. Maldonado ★★☆☆☆ #2613 | Buy | $40.00→ $38.00-5.0% |
|
Aug 05
12:27 UTC
|
RVLV
Revolve Group
|
◎ Target | Anna Andreeva ★★★☆☆ #1158 | Overweight | $27.00→ $30.00+11.1% |
|
Aug 05
12:27 UTC
|
QLYS
Qualys
|
◎ Target | Joseph Gallo ★★★★★ #132 | Hold | $150.00→ $185.00+23.3% |
|
Aug 05
12:27 UTC
|
PINS
Pinterest
|
◎ Target | Barton Crockett ★★★★☆ #650 | Neutral | $24.00→ $25.00+4.2% |
|
Aug 05
12:27 UTC
|
PCTY
Paylocity
|
◎ Target | Allan Verkhovski ★★★☆☆ #1363 | Buy | $150.00→ $180.00+20.0% |
|
Aug 05
12:27 UTC
|
PCRX
Pacira BioSciences
|
◎ Target | Serge Belanger ★★★☆☆ #1891 | Buy | $32.00→ $33.00+3.1% |
|
Aug 05
12:27 UTC
|
OSPN
Onespan
|
◎ Target | Catharine Trebnick ★★★★☆ #950 | Buy | $16.00→ $18.00+12.5% |
|
Aug 05
12:27 UTC
|
MPC
Marathon Petroleum
|
◎ Target | Jason Gabelman ★★★★☆ #522 | Buy | $357.00→ $375.00+5.0% |
|
Aug 05
12:27 UTC
|
LSCC
Lattice Semiconductor
|
◎ Target | Blayne Curtis ★★☆☆☆ #2906 | Buy | $145.00→ $175.00+20.7% |
|
Aug 05
12:27 UTC
|
LSCC
Lattice Semiconductor
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $140.00→ $160.00+14.3% |
|
Aug 05
12:27 UTC
|
KTOS
Kratos Defense & Security Solutions
|
◎ Target | Andre Madrid ★★☆☆☆ #2845 | Buy | $100.00→ $104.00+4.0% |
|
Aug 05
12:27 UTC
|
KIDS
OrthoPediatrics
|
◎ Target | Mike Matson not yet tracked | Buy | $30.00→ $35.00+16.7% |
|
Aug 05
12:27 UTC
|
HUT
Hut 8
|
◎ Target | John Todaro ★☆☆☆☆ #3213 | Buy | $145.00→ $138.00-4.8% |
|
Aug 05
12:27 UTC
|
HNGE
Hinge Health
|
◎ Target | Ryan MacDonald ★★★★☆ #465 | Buy | $76.00→ $97.00+27.6% |
|
Aug 05
12:27 UTC
|
FRSH
Freshworks
|
◎ Target | Billy Fitzsimmons ★★★★★ #204 | Neutral | $10.00→ $12.00+20.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.